A Study to Assess Adverse Events and Change in Disease Activity of Intramuscular AGN-151586 Injection in Adult Participants With Glabellar Lines
Clinical trial NCT05248867 · COMPLETED
Trial details
- NCT number
- NCT05248867
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-16
- Primary completion
- 2023-03-17
- Enrollment
- 638
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.